The global enteral nutrition market garnered $5,661.6 million in 2017 and is projected to reach $10,478.0 million by 2025, registering a CAGR of 7.9% from 2018 to 2025.
Enteral nutrition refers to the process of feeding through the gastrointestinal (GI) tract to fulfill the caloric requirements of patients who suffer from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others. It is prescribed to patients who are unable to consume the requisite nutrients orally due to swallowing difficulties or surgery but have a functional gastrointestinal tract. Enteral nutrients are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes. Generally, enteral feeding is administered to critically ill patients in an operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), or at home.
Increase in incidence of chronic disorders such as cancer and neurological disorders is the key factor driving the growth of the global enteral nutrition market. Moreover, increase in geriatric population and surge in malnutrition cases have supplemented the market growth. Over the years, enteral nutrition has been gaining tremendous response owing to advancement in techniques, configurations, and ingredients. In addition, low cost and complications associated with enteral nutrition boost the market growth. However, stringent governmental regulations and inadvertent dislodgment of tubes that lead to accidental disabilities and deaths hamper the market growth. Conversely, development of new technologically advanced products and high market potential in untapped emerging economies are expected to provide lucrative opportunities for the growth of the market.
The global enteral nutrition market is segmented based on protein composition, distribution channel, form & age group, and region. Based on protein composition, the market is divided into standard protein diet, high protein supplement, protein for diabetes care patient, and others. Based on distribution channel, the market is segmented into hospital sale, retail, and online. Based on form, the market is categorized into powder and liquid. Based on the age group, the market is bifurcated into adult (age >18 years) and pediatrics (age < 18 years). The global enteral nutrition market has been further analyzed across North America, Europe, Asia-Pacific, CIS, and LAMEA.
The key players operating in the value chain of this report include Abbott Laboratories, Nestlé S.A., Danone SA, Fresenius Kabi AG, Mead Johnson Nutrition Company, B. Braun Melsungen AG, Global Health Products, Inc., Meiji Holdings Co., Ltd., Victus, Inc., and Hormel Foods Corporation.
Key Benefits For Enteral Nutrition Market:
- The study provides an in-depth analysis of the global enteral nutrition industry along with the current trends and future estimations to elucidate the investment pockets.
- A comprehensive analysis of the factors that drive and restrict the growth of the market is provided.
- The report provides a quantitative analysis to help stakeholders capitalize on the prevailing market opportunities.
- An extensive analysis of the different segments facilitates to understand various products available in the market.
- The key players are profiled, and their strategies are analyzed thoroughly to gauge the competitive outlook of the industry.
Enteral Nutrition Key Market Segments:
By Protein Composition
Standard Protein diet
High Protein Supplement
Protein for Diabetes Care Patient
By Distribution Channel
By Form & Age Group
Age < 18
Age < 18
Rest of Europe
Rest of Asia-Pacific
Rest of CIS
Rest of LAMEA
1.1. Report description
1.2. Key benefits for stakeholders
1.3. key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyer
3.3.3. Thereat of new entrants
3.3.4. Threat of substitute
3.3.5. Intensity of competitive rivalry
3.4. Top player positioning, 2017
3.5. Market dynamics
220.127.116.11. Increase in demand from end-user industries
18.104.22.168. Promising growth of the surfactant industry
22.214.171.124. Volatility in Raw Material prices
126.96.36.199. Growing demand for Gas Sweetening agents
3.6. End user and competitor analysis
CHAPTER 4: NORTH AMERICA ETHANOLAMINE MARKET, BY PRODUCT
4.1.1. Market size and forecast
4.2. Monoethanolamine (mea)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Diethanolamine (dea)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Triethanolamine (tea)
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: NORTH AMERICA ETHANOLAMINE MARKET, BY APPLICATION
5.1.1. Market size and forecast
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.3. Gas treatment
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.4. Water treatment
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast
5.6.1. Key market trends, growth factors, and opportunities
5.6.2. Market size and forecast
5.7.1. Key market trends, growth factors, and opportunities
5.7.2. Market size and forecast
CHAPTER 6: NORTH AMERICA ETHANOLAMINE MARKET, BY END-USER INDUSTRY
6.1.1. Market size and forecast
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.3. Personal care
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast
6.6. Rubber, oil, & petrochemical
6.6.1. Key market trends, growth factors, and opportunities
6.6.2. Market size and forecast
6.7.1. Key market trends, growth factors, and opportunities
6.7.2. Market size and forecast
CHAPTER 7: NORTH AMERICA ETHANOLAMINE MARKET, BY COUNTRY
7.1.1. Market size and forecast
7.2. North america
7.2.1. Key market trends
7.2.2. Key growth factors, and opportunities
7.2.3. Market size and forecast
188.8.131.52. U.S. Market size and forecast
184.108.40.206. Canada Market size and forecast
220.127.116.11. Mexico Market size and forecast
7.2.4. North America ethanolamine market, by product
18.104.22.168. Market size and forecast
7.2.5. North America ethanolamine market, by application
22.214.171.124. Market size and forecast
7.2.6. North America market size and forecast, by end-user industry
CHAPTER 8: COMPONY PROFILES
8.1. BASF SE
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. HUNTSMAN CORPORATION
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. THE DOW CHEMICAL COMPANY
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. AKZO NOBEL N.V.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. DAICEL CORPORATION
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. INEOS GROUP AG
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. KOCH INDUSTRIES (INVISTA)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.8. MITSUBISHI GAS CHEMICAL COMPANY, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. EASTMAN CHEMICAL COMPANY (TAMINCO)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. SINOPEC CORP
8.10.1. Company over view
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
According to a new report titled, Global Enteral Nutrition Market by Material Type, Filter Module, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025, the global enteral nutrition market size was valued at $5,661.6 million in 2017, and is projected to reach $10,478.0 million in 2025, registering a CAGR of 7.9% from 2018 to 2025. Enteral nutrition is the administration of food supplements using pumps and tubes directly in the gastrointestinal tract of patients who cannot swallow food or get enough nourishment by eating or drinking. These medical devices deliver medications and nutrients directly into the stomach, duodenum, or jejunum either via nose, mouth, or direct percutaneous route.
Increase in prevalence of several chronic disorders such as cancer and neurological disorders worldwide, surge in adoption of enteral nutrition over parenteral nutrition, rise in geriatric population, and growth in malnutrition cases drive the market growth. However, stringent governmental regulations and inadvertent dislodgment of tubes leading to accidental disabilities and deaths impede the growth of the market. Conversely, the development of newer products with minimal side effects and presence of untapped market potential in the emerging economies are expected to provide lucrative growth opportunities for the global enteral nutrition market.
According to the WHO, the number of people diagnosed with diabetes increased from 108 million in 1980 to 422 million in 2014. In addition, the prevalence rate of diabetes in adults over 18 years of age increased from 4.7% in 1980 to 8.5% in 2014. This growth pattern is more evident in middle- and low-income countries. Thus, growing prevalence of diabetes fosters the growth of the enteral nutrition market.
As per the National Cancer Institute data, it is estimated that 1,735,350 new cases of cancer are expected to be diagnosed in the U.S. by the end of 2018. Moreover, according to the Centers for Disease Control and Prevention (CDC) data, about half of all adults (approximately 117 million) worldwide suffered from one or more chronic health conditions in 2012, while diabetes being the most common chronic disease. Therefore, burgeoning number of cancer cases across the globe are expected to increase the adoption of enteral feeding systems, thereby boosting the growth of the enteral nutrition market.
Globally, the geriatric population who are vulnerable to disorders such as cardiovascular, stroke, diabetes, gastric diseases, and intestinal illnesses has increased tremendously in the last few years. According to the data released by the U.S. Census Bureau, in 2015, about 617.1 million of the global population were in the age group of 65 years and above. The number of elderly people is expected to increase by 60% in just 15 years and is projected to grow further in the subsequent two decades. Rapid increase in geriatric population is one of the key drivers of the enteral nutrition market, as they are highly susceptible to various diseases due to decreased immunity and degeneration.
Enteral nutrition is preferred to parenteral nutrition due to improvements in safety and ease of access. In addition, usage of percutaneous jejunostomies, percutaneous dual tube gastrojejunostomies, and nasojejunal tubes has become common with good safety records. Therefore, it is highly acceptable as a home feeding therapy due to numerous advantages of enteral feeding.
The emerging economies of the Asia-Pacific region offer lucrative growth opportunities to the market players owing to improvement in healthcare infrastructure and increase in demand for better healthcare services in the region. Moreover, rise in prevalence of several chronic diseases in the developing countries fuels the demand for enteral nutrition. Moreover, increase in healthcare expenditure in these regions is projected to propel the enteral nutrition market growth.
Digital marketing is now preferred to conventional forms of advertising owing to the increased penetration of internet and social media. Mobile apps and social media are set to play a crucial role in assisting emerging markets, such as India, to catch up with the technical superiority of peer countries such as China.
Indian pharmaceutical companies have begun investing in the digital platform for marketing. In 2016, Sun Pharmaceuticals Industries Ltd., an Indian multinational pharmaceutical company launched its mobile app, RespiTrack, which has features such as medication reminders, pre-programmed alerts, over-the-air review by the doctor and others.
GlaxoSmithKline plc, a British pharmaceutical company equipped its employees with iPads to disseminate real-time information on the developments in therapy areas. In addition, the company used webinars, video chats, information portals, and platforms such as Viva for doctors to push sales.
Key Findings Of Enteral Nutrition Market:
- The protein for diabetes care patient segment by protein composition of enteral nutrition market is anticipated to witness the fastest CAGR of 9.4% from 2018 to 2025.
- The standard protein diet segment by protein composition dominated the global enteral nutrition market in 2017, and it is anticipated to grow at a lucrative CAGR of 7.2% during the forecast period.
- The online segment by distribution channel is anticipated to witness the fastest CAGR of 9.0% in terms of value during the forecast period.
- North America led the global enteral nutrition market in terms of value in 2017 and is anticipated to witness a CAGR of 7.1% during the forecast period.
- By form, the liquid segment dominated the enteral nutrition market in 2017 and is anticipated to witness a significant CAGR of 8.0% during the forecast period.
- The Asia-Pacific region is anticipated to witness the fastest CAGR of 8.8% in terms of value during the forecast period.
The major companies profiled in this report are Abbott Laboratories, Nestl S.A., Danone SA, Fresenius Kabi AG, Mead Johnson Nutrition Company, B. Braun Melsungen AG, Global Health Products, Inc., Meiji Holdings Co., Ltd., Victus, Inc., and Hormel Foods Corporation.
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.